Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

The normal human prostate does not significantly affect blood DHT levels.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Hair loss in women linked to higher sexual dysfunction risk.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Skin aging can be slowed by targeting cells, hormones, and the microbiome.

Hormones play a key role in skin aging, with estrogen and testosterone declines affecting skin health.

A new method effectively detects trace sex hormones in cosmetics, ensuring safety.

Microextraction techniques improve hormone testing while being environmentally friendly.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

PCOS is common, affects hormones, and often diagnosed late, impacting women's quality of life.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.